- Display 15 Products per page
Published: January 1, 2006 | Price: $3,000.00 – $6,000.00
The U.S. Market for OTC anti-infective products surpassed the $2 billion mark last year. Although overall growth is sluggish, the market is a proven revenue source for a number of major brands, and there have been some nice surprises in the performance of some categories, such as first-aid related antiseptic and antibiotic products. This comprehensive report examines all aspects of the U.S. OTC market, including 5-year sales performance by brand and by marketer for the following categories of products: Antifungals...Published: February 1, 2006 | Price: $3,000.00 – $6,000.00
The private label over-the-counter (OTC) market has been gaining ground rapidly over the past five years. The private label sector has shed its image of being a ‘me-too’ version of national brands and worked toward offering quality and innovation at an economical price. With benefits for consumers, retailers, and manufacturers, private label healthcare should experience solid growth through the end of the decade. This report on the U.S. market for OTC private label products presents an in-depth analysis of the...Published: March 1, 2006 | Price: $3,000.00 – $6,000.00
This report on the U.S. market for over-the-counter (OTC) pediatric medications presents an in-depth analysis of the performance of non-prescription pediatric drugs and other selected pediatric healthcare products in the marketplace. The analysis captures the performance of the market players, categories, and leading brands in terms of revenue growth and volume growth in several categories of medication, including cough/cold allergy sinus products; first aid products; internal analgesic products, and other pediatric products (chest rubs, nasal products and bedwetting remedies). In...Published: April 26, 2019 | Price: $3,000.00 – $6,000.00
In vitro diagnostic (IVD) products continue to see positive sales growth in many categories, while others mature. New products, changes in global health spending, regulatory changes in major markets and disease trends are among the factors that produce a constantly changing market picture. IVD Market Trends Summary features current trends and updates in the worldwide IVD market. Highlights of these updates include: Market developments in developing markets – Latin America, the Middle East and Eastern Europe Effects of PAMA in...Published: May 8, 2019 | Price: $3,000.00 – $6,000.00
Biopharmaceuticals are synthetic or recombinant versions of natural biologic substances, including proteins such as enzymes or antibodies, and nucleic acids such as DNA or RNA. Generic products are non-patented chemical and therapeutic equivalents of brand name drugs. However, biosimilars are not generic biologics because there can be no generic form of biologics due to the complex process of creating biologics. Biosimilar Market Trends 2019 is designed to provide a snapshot of issues and trends that are affecting the biosimilar market...Published: August 6, 2019 | Price: $3,000.00 – $6,000.00
With a demand in healthcare to lower unneeded emergency room visits and provide more options for patients, more and more customers will seek urgent care in the coming years. This report will provide marketers and business planners with the important data they need on this emerging channel of business. Kalorama has covered the urgent care trend with estimates of its impact on IVD and imaging since 2013. This Kalorama Information report, The Market for Urgent Care Centers, is a detailed...Published: October 31, 2019 | Price: $3,000.00 – $6,000.00
This report is an update on the worldwide in vitro diagnostics (IVD) market, examining several of the factors that currently contribute to the evolving IVD market picture. The topics discussed are the following: The Worldwide IVD Market, 2019-2024 Market Developments in Selected Markets – North America, EU15/Western Europe, Eastern Europe, Japan and China Genetic Testing New POC Innovations Cancer Testing and Personalized Medicine Hematology Glucose Monitoring Advancements HbA1c Testing New Developments in Infectious Diseases Cytology - Increasing Molecular Dx Options...Published: May 27, 2020 | Price: $3,000.00 – $6,000.00
In light of the COVID-19 (coronavirus) pandemic, it is extremely timely to present a report on the status quo in emerging infectious diseases. While the current pandemic is troublesome and has disrupted normal life, it will follow its course and then fade away. Where could the next pandemic or epidemic come from? There are a number of diseases currently tracking as moving from the developed world to the developing world? Kalorama has addressed emerging infectious disease since our first study nine...Published: October 26, 2020 | Price: $3,000.00 – $6,000.00
The diagnosis and treatment of sepsis is one of the biggest challenges facing healthcare currently. In the United States, there are around 1.7 million cases of sepsis per year, resulting in approximately 270,000 deaths. Overall, the costs associated with sepsis make it the most expensive condition treated in US hospitals. This report provides comprehensive information on products in the sepsis market, as well as: Sepsis Detection Practice Trends Sepsis Related Biomarkers: Advantages and Disadvantages Markets for Sepsis-Related Testing Mass...Published: February 16, 2021 | Price: $3,000.00 – $6,000.00
As the unfortunate milestone of one full year of the global COVID-19 pandemic worldwide is reached, the diagnostic industry has been changed, perhaps permanently. Hundreds of test products are on the market to detect the virus, both for its presence and immune response. And billions of dollars have been added to the in vitro diagnostic market. Companies have doubled and tripled revenues, bought new companies, increased manufacturing, shifted focus to infectious diseases and launched new products. "A 38 Billion Dollar Market...Published: March 12, 2021 | Price: $3,000.00 – $6,000.00
What is the Size of the IVD Market in 2021? What Impact has COVID-19 Had on IVD Markets? What Major Trends are Affecting the Market in 2021? Diagnostic test products have never been more important. This report, 2021 IVD Market Update and COVID-19 Impact, is an update of the market for in vitro diagnostics products from Kalorama's analysts to reflect the latest information. As part of its coverage, this report contains market sizing for the following categories of IVD: Clinical...Published: April 15, 2021 | Price: $3,000.00 – $6,000.00
This first edition report At-Home Testing: COVID-19 Trends and Future Potential provides an overview of trends and developments in the home testing industry for the pandemic of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This report covers trends that have occurred since the pandemic was declared in 2020 to the recent present – March 31, 2021. For the purpose of this report, Kalorama Information concludes that the accepted definition of a home or...Published: July 12, 2021 | Price: $3,000.00 – $6,000.00
A variety of demographic, business, and government trends are contributing to rising out-of-pocket (OOP) healthcare expenses in the United States. Out-of-Pocket Healthcare Expenditures in the United States, 5th Edition examines these trends in detail, focusing on the financial aspects of OOP spending growth and quantifying the growth of OOP spending with forecasts of total expenditures and specialized healthcare financing. Total Expenditures The report examines past, current, and future levels of U.S. out-of-pocket healthcare expenditures both in total and as specific sub-groups...Published: September 29, 2021 | Price: $3,000.00 – $6,000.00
A considerable number of diagnostic tests are available or in development for the detection of autoimmune diseases. Because of this potentially large and growing market, vast opportunity exists for discovery and advancement in this arena. Competition within this market is expected to increase dramatically. However, in fledgling autoimmune IVD diagnostic testing markets, a golden opportunity exists to capitalize on new testing innovations without significant competition. In terms of test options, a substantial amount of overlap exists in the various autoimmune...Published: September 29, 2021 | Price: $3,000.00 – $6,000.00
Allergies are a number of conditions that are caused by hypersensitivity to a substance in the environment. Allergies can run the gamut of seasonal nuisances to life-threatening ordeals. Allergy statistics show that these conditions are constantly present in lives and are not going away. Factors contributing to allergies worldwide include: Environmental pollution Changing lifestyles and dietary patterns Indoor pollution An individual who is overly reactive to an antigen that is tolerated by most others is said to be hypersensitive (allergic). ...